12/14/2011 Nu Skin Enterprises Acquires LifeGen Technologies
Press Release
10/21/2010 - LifeGen Technologies awarded Phase I SBIR grant from the National Institute on Aging
More information here
10/22/2009 - Nu Skin signs Research Agreement with LifeGen Technologies
LifeGen Co-founder Richard Weindruch featured on CBS's 60 Minutes news story on resveratrol and calorie
restriction
1/25/2009 Link
to story and video
LifeGen researchers report that consumption of a low dose of the red wine molecule resveratrol mimics the gene
expression profile of mice subjected to a calorie-restricted diet.
6/4/2008 - PLoS
ONE
Richard Weindruch Ph.D.
Director and Co-founder
For 30 years, Dr. Weindruch has studied the retardation of aging by caloric restriction (CR). He earned his B.S. and M.S. in Biology at the University of Illinois (Urbana) and his Ph.D. (1978) in Experimental Pathology at UCLA under the direction of Dr. Roy Walford. He has authored two books and more than 130 scientific articles. In 1988, Drs. Weindruch and Walford published “The Retardation of Aging and Disease by Dietary Restriction,” which is widely regarded as the founding text for this growing field.
Dr. Weindruch has received several awards for his research including the 1998 Kleemeir Award from the Gerontological Society of America, the 2000 Nathan Shock Award from the NIA and the 2000 Glenn Award from the Paul Glenn Foundation. He is directing a large, NIA-funded study in rhesus monkeys to determine whether CR retards the aging process in primates. He also oversees other NIA-funded projects exploring the mechanism by which CR retards the aging process in mice.